• 1
    Seeman E, Melton LJ, O'Fallon WM, Riggs BL 1983 Risk factors for spinal osteoporosis in men. Am J Med 75:977983.
  • 2
    Melton LJ III, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL 1989 Epidemiology of vertebral fractures in women. Am J Epidemiol 129:10001011.
  • 3
    Pocock N, Eisman J, Gwinn T, Sambrook P, Kelly P, Freund J, Yeates M 1989 Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass. J Bone Miner Res 4:441448.
  • 4
    Slemenda CW, Hui SL, Longcope C, Wellman H, Johnston CC Jr 1990 Predictors of bone mass in perimenopausal women. Ann Intern Med 112:96101.
  • 5
    Felson DT, Zhang Y, Hannan MT, Anderson JJ 1993 Effects of weight, and body mass index on bone mineral density in men and women. J Bone Miner Res 8:567573.
  • 6
    Lindsay R, Cosman F, Herrington BS, Himmelstein S 1992 Bone mass and body composition in normal women. J Bone Miner Res 7:5562.
  • 7
    Edelstein SH, Barrett-Connor E 1993 Relationship between body size and bone mineral density in elderly and women. Am J Epidemiol 138:160169.
  • 8
    Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES 1995 Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:11181123.
  • 9
    Khosla S, Atkinson EJ, Riggs BL, Melton LJ 1996 Relationship between body composition and bone mass in women. J Bone Miner Res 11:857863.
  • 10
    Reid IR, Plank LD, Evans MC 1992 Fat mass is an important determinant of whole body bone density in premenopausal women but not in men. J Clin Endocrinol Metab 75:779782.
  • 11
    Hla MM, Davis JW, Ross PD, Wasnick RD, Yates AJ, Ravn P, Hosking DJ, McClung MR, the Early Postmenopausal Intervention Cohort (EPIC) Study Group 1996 A multicenter study of the influence of fat and lean mass on bone mineral content: Evidence for difference in their relative influence at major fracture sites. Am J Clin Nutr 64:354360.
  • 12
    Tremollieres FA, Pouilles JM, Ribot C 1993 Vertebral postmenopausal bone loss is reduced in overweight women: A longitudinal study in 155 early postmenopausal women. J Clin Endocrinol Metab 77:683686.
  • 13
    Revilla M, Villa LF, Sánchez-Atrio A, Hernández ER, Rico H 1997 Influence of body mass index on the age-related slope of total and regional bone mineral content. Calcif Tissue Int 61:134138.
  • 14
    Galvard H, Elmstahl S, Elmstahl B, Samuelsson SM, Robertsson E 1996 Differences in body composition between female geriatric hip fracture patients and healthy controls: Body fat is more important as an explanatory factor for the fracture than body weight and lean body mass. Aging Clin Exp Res 8:282286.
  • 15
    Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas PD, Ribot C, Sebert JL, Breart G, Meunier PJ 1998 How hip and whole-body bone mineral density predict hip fracture in elderly women: The EPIDOS Prospective Study. Osteoporos Int 8:247254.
  • 16
    Schindler AE, Ebert A, Friedrich E 1972 Conversion of androstenedione to estrone by human fat tissue. J Clin Endocrinol Metab 35:627630.
  • 17
    Grodin JM, Siiteri PK, MacDonald PC 1973 Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 36:207214.
  • 18
    Heshmati HM, Khosla S, Robins SP, Geller N, McAlister CA, Riggs BL 1997 Endogenous residual estrogen levels determine bone resorption even in late postmenopausal women. J Bone Miner Res 12:S1;S121.
  • 19
    Khosla S, Melton LJ III, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:22662274.
  • 20
    Reid IR, Ames R, Evans MC, Sharpe S, Gamble G, France JT, Lim TMT, Cundy TF 1992 Determinants of total body and regional bone mineral density in normal postmenopausal women. J Clin Endocrinol Metab 75:4551.
  • 21
    Kleerekoper M, Nelson DA, Peterson EL, Wilson PS, Jacobsen G, Longcope C 1994 Body composition and gonadal steroids in older white and black women. J Clin Endocrinol Metab 79:775779.
  • 22
    Aloia JF, Vaswani A, Ma R, Flaster E 1995 To what extent is bone mass determined by fat-free or fat mass? Am J Clin Nutr 61:11101114.
  • 23
    Douchi T, Oki T, Nakamura S, Ijuin H, Yamamoto S, Nagata Y 1997 The effect of body composition on bone density in pre- and postmenopausal women. Maturitas 27:5560.
  • 24
    Martini G, Valenti R, Giovani S, Nuti R 1997 Age-related changes in body composition of healthy and osteoporotic women. Maturitas 27:2533.
  • 25
    Reid IR, Evans MC, Cooper GJ, Ames RW, Stapleton J 1993 Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol 265:E655—E659.
  • 26
    Hickman J, McElduff A 1989 Insulin promotes growth of the cultured rat osteosarcoma cell line UMR106–01: An osteoblast-like cell. Endocrinology 124:701706.
  • 27
    Barrett-Connor E, Kritz-Silverstein D 1996 Does hyperinsulinemia preserve bone? Diabetes Care 19:13881392.
  • 28
    Thomas DM, Ng KW, Best JD 1997 Insulin and bone: A clinical and scientific review. Endocrinol Metab 4:517.
  • 29
    Cinti S, Frederich RC, Zingaretti MC, Dematteis R, Flier JS, Lowell BB 1997 Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology 138:797804.
  • 30
    Maffei M, Halaas JL, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM 1995 Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1:11551161.
  • 31
    Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF 1996 Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292295.
  • 32
    Thomas T, Burguera B, Melton LJ III, Atkinson EJ, Riggs BL, Khosla S 2000 Relationship of serum leptin levels with body composition, sex steroid, and insulin levels in men and women. Metabolism 49:12781284.
  • 33
    Rosenbaum M, Leibel RL, Hirsch J 1997 Obesity. N Engl J Med 337:396407.
  • 34
    Couce ME, Burguera B, Parisi JE, Jensen MD, Lloyd RV 1997 Localization of the leptin receptor in the human brain. Neuroendocrinology 66:145150.
  • 35
    Yu WH, Kimura M, Walczewska A, Karanth S, McCann SM 1997 Role of leptin in hypothalamic-pituitary function. Proc Natl Acad Sci USA 94:10231028.
  • 36
    Spicer LJ, Francisco CC 1997 The adipose obese gene product, leptin: Evidence of a direct inhibitory role in ovarian function. Endocrinology 138:33743379.
  • 37
    Caprio M, Isidori AM, Carta AR, Moretti C, Dufau ML, Fabbri A 1999 Expression of functional leptin receptors in rodent Leydig cells. Endocrinology 140:493947.
  • 38
    Bornstein SR, Uhlmann K, Haidan A, Ehrhart-Bornstein M, Scherbaum WA 1997 Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: Leptin inhibits cortisol release directly. Diabetes 46:12351238.
  • 39
    Henry BA, Goding JW, Alexander WS, Tilbrook AJ, Canny BJ, Dunshea F, Rao A, Mansell A, Clarke IJ 1999 Central administration of leptin to ovariectomized ewes inhibits food intake without affecting the secretion of hormones from the pituitary gland: Evidence for a dissociation of effects on appetite and neuroendocrine function. Endocrinology 140:11751182.
  • 40
    Bennett BD, Solar GP, Yuan JQ, Mathias J, Thomas GR, Matthews W 1996 A role for leptin and its cognate receptor in hematopoiesis. Curr Biol 6:11701180.
  • 41
    Cioffi JA, Shafer AW, Zupancic TJ, Smith-Gbur J, Mikhail A, Platika D, Snodgrass HR 1996 Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction. Nat Med 2:585589.
  • 42
    Gainsford T, Willson TA, Metcalf D, Handman E, Mcfarlane C, Ng A, Nicola NA, Alexander WS, Hilton DJ 1996 Leptin can induce proliferation, differentiation, and functional activation of hemopoeitic cells. Proc Natl Acad Sci USA 93:1456414568.
  • 43
    Mikhail AA, Beck EX, Shafer A, Barut B, Gbur JS, Zupancic TJ, Schweitzer AC, Cioffi JA, Lacaud G, Ouyang B, Keller G, Snodgrass HR 1997 Leptin stimulates fetal and adult erythroid and myeloid development. Blood 89:15071512.
  • 44
    Umemoto Y, Tsuji K, Yang FC, Ebihara Y, Kaneko A, Furukawa S, Nakahata T 1997 Leptin stimulates the proliferation of murine myelocytic and primitive hematopoeitic progenitor cells. Blood 90:34383443.
  • 45
    Liu YL, Emilsson V, Cawthorne MA 1997 Leptin inhibits glycogen synthesis in the isolated soleus muscle of obese (ob/ob) mice. FEBS Lett 411:351355.
  • 46
    Kellerer M, Koch M, Metzinger E, Mushack J, Capp E, Häring HU 1997 Leptin activates PI-3 kinase in C2C12 myotubes via janus kinase-2 (JAK-2) and insulin receptor substrate-2 (IRS-2) dependent pathways. Diabetologia 40:13581362.
  • 47
    Tsuchiya T, Shimizu H, Horie T, Mori M 1999 Expression of leptin receptor in lung: Leptin as a growth factor. Eur J Pharmacol 365:273279.
  • 48
    Morton NM, Emilsson V, Liu YL, Cawthorne MA 1998 Leptin action in intestinal cells. J Biol Chem 273:2619426201.
  • 49
    Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, Flores-Riveros JR 1998 Biological action of leptin as an angiogenic factor. Science 281:16831686.
  • 50
    Bai Y, Zhang S, Kim KS, Lee JK, Kim KH 1996 Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 271:1393913942.
  • 51
    Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH 1997 Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94:46374641.
  • 52
    Flier JS 1997 Leptin expression and action: New experimental paradigms. Proc Natl Acad Sci USA 94:42424245.
  • 53
    Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG 1997 Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci USA 94:1107311078.
  • 54
    Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE, Boss O, Pernin A, Chin WW, Cusin I, Rohner-Jeanrenaud F, Burger AG, Zapf J, Meier CA 1997 Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100:28582864.
  • 55
    Owen M 1985 Lineage of osteogenic cells and their relationship to the stromal system. In: PeckWA (ed.) Bone and Mineral Research, vol 3. Elsevier, Amsterdam, The Netherlands, pp. 123.
  • 56
    Thomas T, Gori F, Khosla S, Jensen MD, Burguera B, Riggs BL 1999 Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 140:16301638.
  • 57
    Bassilana F, Susa M, Keller HJ, Halleux C 2000 Human mesenchymal stem cells undergoing osteogenic differentiation express leptin and functional leptin receptor. J Bone Miner Res 15:S1;S378.
  • 58
    Cornish J, Callon KE, Bava U, Lin QX, Naot D, Hill BL, Broom ND, Reid ID 2001 The direct acions of leptin on bone cells increase bone strength in vivo -an explanation of low fracture rates in obesity. Bone 28(Suppl):S88.
  • 59
    Steppan CM, Crawford DT, Chidsey-Frink KL, Ke H, Swick AG 2000 Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92:7378.
  • 60
    Reseland JE, Syversen U, Bakke I, Qvigstad G, Eide LG, Hjertner O, Gordeladze JO, Drevon CA 2001 Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. J Bone Miner Res 16:14261433.
  • 61
    Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen JH, Vinson C, Rueger JM, Karsenty G 2000 Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100:197207.
  • 62
    Hoggard N, Hunter L, Duncan JS, Williams LM, Trayhurn P, Mercer JG 1997 Leptin and leptin receptor mRNA and protein expression in the murine fetus and placenta. Proc Natl Acad Sci USA 94:1107311078.
  • 63
    Kume K, Satomura K, Nishisho S, Kitaoka E, Yamanouchi K, Tobiume S, Nagayama M 2002 Potential role of leptin in endochondral ossification. J Histochem Cytochem 50:159169.
  • 64
    Takahashi Y, Okimura Y, Mizuno I, Iida K, Takahashi T, Kaji H, Abe H, Chihara K 1997 Leptin induces mitogen-activated protein kinase-dependent proliferation of C3H10T1/2 cells. J Biol Chem 272:1289712900.
  • 65
    Iwaniec UT, Shearon CC, Heaney RP, Cullen DM, Yee JA 1998 Leptin increases number of mineralized bone nodules in vitro. Bone 23(Suppl):S212.
  • 66
    Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL 2001 Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:1444314450.
  • 67
    Hu E, Kim JB, Sarraf P, Spiegelman BM 1996 Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274:21002103.
  • 68
    Burguera B, Hofbauer L, Thomas T, Gori F, Lassam J, Laasko K, Evans G, Khosla S, Riggs BL, Turner RT 2001 Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142:35463553.
  • 69
    Holloway WR, Collier FM, Aitken CJ, Malakellis M, Gough TJ, Myers DE, Collier GR, Nicholson GC 2000 Leptin inhibits osteoclast generation. J Bone Miner Res 15:S1;S174.
  • 70
    Gabay C, Dreyer M, Pellegrinelli N, Chicheportiche R, Meier CA 2001 Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 86:783789.
  • 71
    Gregoire Nyomba BL, Johnson M, Berard L, Murphy LJ 1999 Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 48:840844.
  • 72
    Flier JS, Harris M, Hollenberg AN 2000 Leptin, nutrition, and the thyroid: The why, the wherefore, and the wiring J Clin Invest 105:859861.
  • 73
    Foldes J, Shih MS, Levy J 1992 Bone structure and calcium metabolism in obese Zucker rats. Int J Obes 16:95102.
  • 74
    Holzmann T, Schilling AF, Beil T, Rueger JM, Karsenty G, Amling M 2000 Central control of bone mass by leptin in rats. J Bone Miner Res 15:S1;S471.
  • 75
    Liu C, Grossman A, Bain S, Strachan M, Puerner D, Bailey C, Humes J, Lenox J, Yamamoto G, Sprugel K, Kuiper J, Weigle S, Durman D, Moore E 1997 J Bone Miner Res 12:S1;S115.
  • 76
    Spiegelman BM, Flier JS 2001 Obesity and the regulation of energy balance. Cell 104:531543.
  • 77
    Burguera B, Curran G, Couce ME, Lamsam J, Cleary M, Poduslo J 2000 Obesity is associated with a decreased of leptin transport across the blood brain barrier and up regulation of leptin receptor in the hypothalamus. Diabetes 49:12191223.
  • 78
    Couce ME, Green D, Brunetto A, Achim C, Lloyd RV, Burguera B 2001 Limited brain access for leptin in obesity. Pituitary 4:101110.
  • 79
    Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV 1996 Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance. Lancet 348:159161.
  • 80
    Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D 1996 Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nat Med 2:589593.
  • 81
    Nam SY, Kratzsch J, Kim KW, Kim KR, Lim SK, Marcus C 2001 Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-MSH in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab 86:48494853.
  • 82
    El-Haschimi K, Pierroz DD, Hileman SM, Bjorbaek C, Flier JS 2000 Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest 105:18271832.
  • 83
    Lin S, Thomas TC, Storlien LH, Huang XF 2000 Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord 24:639646.
  • 84
    Casanueva FF, Dieguez C 1999 Neuroendocrine regulation and actions of leptin. Front Neuroendocrinol 20:317363.
  • 85
    Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H 2002 Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109:915921.
  • 86
    Thomas T, de Vittoris R, David VN, Vico L, Lafage-Proust MH, Alexandre C 2001 Leptin prevents disuse-induced bone loss in tail-suspended female rats. J Bone Miner Res 16:S1;S143.
  • 87
    Thomas T, Burguera B, Melton LJ III, Atkinson EJ, Riggs BL, Khosla S 2001 Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women. Bone 29:114120.
  • 88
    Goulding A, Taylor RW 1998 Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in post-menopausal women. Calcif Tissue Int 63:456458.
  • 89
    Yamauchi M, Sugimoto T, Yamaguchi T, Nakaoka D, Kanzawa M, Yano S, Ozuru R, Sugishita T, Chihara K 2001 Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) 55:341347.
  • 90
    Rauch F, Blum WF, Klein K, Allolio B, Schonau E 1998 Does leptin have an effect on bone in adult women? Calcif Tissue Int 63:453455.
  • 91
    Odabasi E, Ozata M, Turan M, Bingol N, Yonem A, Cakir B, Kutlu M, Ozdemir IC 2000 Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170173.
  • 92
    Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R 2001 Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:1137.
  • 93
    Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM, Nicholson GC 2001 Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 86:18841887.
  • 94
    Matkovic V, Ilich JZ, Skugor M, Badenhop NE, Goel P, Clairmont A, Klisovic D, Nahhas RHW, Landoll JD 1997 Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab 82:32393245.
  • 95
    Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K 1997 Nonadipose tissue production of leptin. Leptin as a novel placenta-derived hormone in humans. Nat Med 3:10291033.
  • 96
    Boguszewski M, Dahlgren J, Bjarnason R, Rosberg S, Carlsson LMS, Albertssonwikland K 1997 Serum leptin in short children born small for gestational age. Relationship with the growth response to growth hormone treatment. Eur J Endocrinol 137:387395.
  • 97
    Harigaya A, Nagashima K, Nako Y, Morikawa A 1997 Relationship between concentration of serum leptin and fetal growth. J Clin Endocrinol Metab 82:32813284.
  • 98
    Christou H, Connors JM, Ziotopoulou M, Hatzidakis V, Papathanassoglou E, Ringer SA, Mantzoros CS 2001 Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth. J Clin Endocrinol Metab 86:935938.
  • 99
    Varvarigou A, Mantzoros CS, Beratis NG 1999 Cord blood leptin concentrations in relation to intrauterine growth. Clin Endocrinol (Oxf) 50:177183.
  • 100
    Grinspoon S, Miller K, Coyle C, Krempin J, Armstrong C, Pitts S, Herzog D, Klibanski A 1999 Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab 84:20492055.
  • 101
    Karlsson MK, Weigall SJ, Duan Y, Seeman E 2000 Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa. J Clin Endocrinol Metab 85:31773182.
  • 102
    Warren MP, Voussoughian F, Geer EB, Hyle EP, Adberg CL, Ramos RH 1999 Functional hypothalamic amenorrhea: Hypoleptinemia and disordered eating. J Clin Endocrinol Metab 84:8737.
  • 103
    Shirakura Y, Sugiyama T, Tanaka H, Taguchi T, Kawai S 2000 Hyperleptinemia in female patients with ossification of spinal ligaments. Biochem Biophys Res Commun 267:752755.
  • 104
    Ozata M, Ozdemir IC, Licinio J 1999 Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 84:36863695.
  • 105
    Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S 1999 Brief Report: Effects of Recombinant Leptin Therapy in a Child with Congenital Leptin Deficiency. N Engl J Med 341:879884.